FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998704610> ?p ?o ?g. }

• W1998704610 endingPage "120" @default.
• W1998704610 startingPage "108" @default.
• W1998704610 abstract "Atherosclerotic stenosis of the major intracranial arteries is the most common cause of ischemic stroke. There are limited treatments for severe intracranial stenosis, and stent placement versus medical treatment remains controversial. The aim of this study was to compare functional outcomes of these two modalities in patients with severe symptomatic intracranial stenosis.At a single center, between 2008 and 2011, patients with angiographically demonstrated severe (70-90%) symptomatic intracranial atherosclerosis were divided into two groups: group A, which received only medical treatment, and group B, which underwent endovascular stent implant treatment. The severity and location of the stenosis was determined by digital subtraction angiography and the Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) trial criteria in all patients. The exclusion criteria were: specific causes other than atherosclerosis, such as artery dissection, fibromuscular dysplasia, vasculitis, radiation and intracranial hemorrhage, focal neurological deficit that did not correlate to internal carotid artery or middle cerebral artery stenosis. All procedures were done under light anesthesia. Technical success was defined as the reduction of stenosis to <30% with complete enveloping of the lesion after the procedure. Early and late adverse events and functional outcomes were compared between the groups using the modified Rankin Scale (mRS).Overall, 63 patients (29 in group A and 34 in group B) were evaluated and followed for a mean period of 15.22 months (range 6-25). The technical success rate was 97% in a total of 34 stents in 34 patients. There was no difference between the early (within 30 days) adverse event rates of the two groups. The median follow-up duration for the stent implant patients was 15 months (range 6-25), and for the medically treated cohort it was 14 months (range 8-25). The re-stenosis rate was 5.8% and the total number of late (>30 days) adverse events, including stroke, myocardial infarction and death, was 1 (2.9%) and 6 (20.7%) in the stent implant and medical groups, respectively (p = 0.042). The stent implant group had significantly better favorable functional outcomes according to the mRS than the medical group (93.9 vs. 63.0%). The cumulative secondary adverse event-free survival was significantly lower in the stent implant group.Stent implants can be considered more durable and safe for patients with symptomatic severe stenosis of the internal carotid artery or middle cerebral artery, despite optimal medical therapy. Randomized, multicenter trials are required to confirm these results." @default.
• W1998704610 created "2016-06-24" @default.
• W1998704610 creator A5001127172 @default.
• W1998704610 creator A5006186518 @default.
• W1998704610 creator A5008736626 @default.
• W1998704610 creator A5015387398 @default.
• W1998704610 creator A5032789578 @default.
• W1998704610 creator A5044859383 @default.
• W1998704610 creator A5078199591 @default.
• W1998704610 creator A5078599619 @default.
• W1998704610 date "2012-11-01" @default.
• W1998704610 modified "2023-10-11" @default.
• W1998704610 title "A Comparison of Stent Implant versus Medical Treatment for Severe Symptomatic Intracranial Stenosis: A Controlled Clinical Trial" @default.
• W1998704610 cites W1553488698 @default.
• W1998704610 cites W1946071951 @default.
• W1998704610 cites W1967222605 @default.
• W1998704610 cites W1970693385 @default.
• W1998704610 cites W1973625401 @default.
• W1998704610 cites W1985759654 @default.
• W1998704610 cites W1988391034 @default.
• W1998704610 cites W1992630417 @default.
• W1998704610 cites W2003100736 @default.
• W1998704610 cites W2032646409 @default.
• W1998704610 cites W2037199765 @default.
• W1998704610 cites W2038776736 @default.
• W1998704610 cites W2054973615 @default.
• W1998704610 cites W2056652447 @default.
• W1998704610 cites W2057160018 @default.
• W1998704610 cites W2057207693 @default.
• W1998704610 cites W2059302638 @default.
• W1998704610 cites W2067903456 @default.
• W1998704610 cites W2074324015 @default.
• W1998704610 cites W2082460690 @default.
• W1998704610 cites W2100598555 @default.
• W1998704610 cites W2123634131 @default.
• W1998704610 cites W2129496617 @default.
• W1998704610 cites W2130464818 @default.
• W1998704610 cites W2133963928 @default.
• W1998704610 cites W2140077977 @default.
• W1998704610 cites W2149095969 @default.
• W1998704610 cites W2159643375 @default.
• W1998704610 cites W2159739992 @default.
• W1998704610 cites W2160507768 @default.
• W1998704610 cites W2167806412 @default.
• W1998704610 cites W2413870938 @default.
• W1998704610 cites W2491061016 @default.
• W1998704610 cites W1472337066 @default.
• W1998704610 doi "https://doi.org/10.1159/000344004" @default.
• W1998704610 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3567882" @default.
• W1998704610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23599702" @default.
• W1998704610 hasPublicationYear "2012" @default.
• W1998704610 type Work @default.
• W1998704610 sameAs 1998704610 @default.
• W1998704610 citedByCount "15" @default.
• W1998704610 countsByYear W19987046102013 @default.
• W1998704610 countsByYear W19987046102014 @default.
• W1998704610 countsByYear W19987046102015 @default.
• W1998704610 countsByYear W19987046102016 @default.
• W1998704610 countsByYear W19987046102017 @default.
• W1998704610 countsByYear W19987046102019 @default.
• W1998704610 countsByYear W19987046102020 @default.
• W1998704610 countsByYear W19987046102021 @default.
• W1998704610 countsByYear W19987046102022 @default.
• W1998704610 countsByYear W19987046102023 @default.
• W1998704610 crossrefType "journal-article" @default.
• W1998704610 hasAuthorship W1998704610A5001127172 @default.
• W1998704610 hasAuthorship W1998704610A5006186518 @default.
• W1998704610 hasAuthorship W1998704610A5008736626 @default.
• W1998704610 hasAuthorship W1998704610A5015387398 @default.
• W1998704610 hasAuthorship W1998704610A5032789578 @default.
• W1998704610 hasAuthorship W1998704610A5044859383 @default.
• W1998704610 hasAuthorship W1998704610A5078199591 @default.
• W1998704610 hasAuthorship W1998704610A5078599619 @default.
• W1998704610 hasBestOaLocation W19987046101 @default.
• W1998704610 hasConcept C126322002 @default.
• W1998704610 hasConcept C126838900 @default.
• W1998704610 hasConcept C127413603 @default.
• W1998704610 hasConcept C141071460 @default.
• W1998704610 hasConcept C197934379 @default.
• W1998704610 hasConcept C2778286760 @default.
• W1998704610 hasConcept C2778333808 @default.
• W1998704610 hasConcept C2778583881 @default.
• W1998704610 hasConcept C2780007028 @default.
• W1998704610 hasConcept C2780643987 @default.
• W1998704610 hasConcept C2780645631 @default.
• W1998704610 hasConcept C2780931571 @default.
• W1998704610 hasConcept C3020199598 @default.
• W1998704610 hasConcept C541997718 @default.
• W1998704610 hasConcept C71924100 @default.
• W1998704610 hasConcept C78519656 @default.
• W1998704610 hasConceptScore W1998704610C126322002 @default.
• W1998704610 hasConceptScore W1998704610C126838900 @default.
• W1998704610 hasConceptScore W1998704610C127413603 @default.
• W1998704610 hasConceptScore W1998704610C141071460 @default.
• W1998704610 hasConceptScore W1998704610C197934379 @default.
• W1998704610 hasConceptScore W1998704610C2778286760 @default.
• W1998704610 hasConceptScore W1998704610C2778333808 @default.
• W1998704610 hasConceptScore W1998704610C2778583881 @default.

• next